PI
CRL icon

PGGM Investments’s Charles River Laboratories CRL Stock Holding History

PGGM Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$235K Hold
623
– – ﹤0.01% 355
2021
Q4 		$235K Buy
+623
New +$242K ﹤0.01% 355

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PGGM Investments's CRL Position: Q1 2022 in Review

PGGM Investments held its Charles River Laboratories (CRL) position steady in Q1 2022 at 623 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #355.

PGGM Investments first reported a position in CRL in Q4 2021 and has held it in 2 quarters since. 644 funds tracked by Wall St. Rank hold CRL as of Q1 2022.

  • PGGM Investments held 623 shares of Charles River Laboratories worth $235K as of Q1 2022.
  • PGGM Investments left its Charles River Laboratories share count unchanged in Q1 2022.
  • Charles River Laboratories made up ﹤0.01% of PGGM Investments's portfolio in Q1 2022, its #355 holding.
  • PGGM Investments first reported a position in Charles River Laboratories in Q4 2021 and has held it in 2 quarters since.
  • 644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2022.

Based on PGGM Investments's 13F filing for Q1 2022, filed 25 Apr 2022.